The present invention provides for a pharmaceutical composition comprising a therapeutically effect amount of an isolated peptide having {HEAD ~ an amino acid sequence} corresponding to {TAIL ~ the amino acid sequence} of a V domain of RAGE and a pharmaceutically acceptable carrier 
The present invention provides for a pharmaceutical composition comprising a therapeutically effect amount of an isolated peptide having { HEAD ~ an amino acid sequence } corresponding to { TAIL ~ the amino acid sequence } of a V domain of RAGE and a pharmaceutically acceptable carrier
OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH HEAD HEAD HEAD HEAD HEAD HEAD HEAD HEAD REL REL TAIL TAIL TAIL TAIL TAIL TAIL TAIL TAIL OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH